The Evolution of Garden Health

Garden Health has experienced significant growth since its inception, transitioning from a startup to a publicly traded company within a decade. Initially aiming to revolutionize cancer diagnosis through liquid biopsies, the company focused on providing information throughout the cancer care continuum via simple blood tests. Their systematic approach began with advanced cancer patients and evolved to offer solutions for cancer survivors and early detection of colorectal cancer with the recently launched Shield test. Now, after ten years, Garden Health is the only company with commercial products in all three crucial areas: late-stage cancer, cancer survivors, and average-risk individuals.